Butala Emporium, Inc. Recall: The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.

🇺🇸 United States

1. August 27, 2015 - Recall initiated
2. April 5, 2017 - Reported by source
3. June 13, 2018 - Recall terminated

Official source record

Agency

FDA

Dataset

FDA Food Enforcement (Recalls)

Recall number

F-1814-2017

Event ID

72087

Status

Terminated

Classification

Class I

Company

Butala Emporium, Inc.

Product description

Baidyanath brand Agnitundi Bati, Dietary Supplement, 80 Tablets -- Product of India --- Mfd in India - Shree Baidyanath Ayurved Bhawan (P) Ltd. 1 Gupta Lane, Kolkata 700006

Quantity

173 bottles

Reason

The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.

Recall initiation date

August 27, 2015

Report date

April 5, 2017

Classification date

Not published in this source record

Termination date

June 13, 2018

Distribution pattern

NY (via 3 retail stores) and directly to 26 individual consumers (CT, FL, HI, NJ, PA, OH, MA, District of Columbia, VT & PR)

UPC, lot, and code information

Batch No. 018, Expiry Date 02/2016

Voluntary or mandated

Voluntary: Firm initiated

Initial notification method

Telephone

Source last updated

Not tracked separately from the Public Health Trace retrieval date below

Public Health Trace retrieval date

July 18, 2026 ET

Other products recalled under this same event

This recall shares FDA event ID 72087 with 9 other product entries in Public Health Trace.

Responsible company: Butala Emporium, Inc.

Other recalls from Butala Emporium, Inc.

A map highlighting the states named in the source's distribution description.

Distributed No data published

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map

State	Distributed
New York	1
Connecticut	1
Florida	1
Hawaii	1
New Jersey	1
Pennsylvania	1
Ohio	1
Massachusetts	1
Vermont	1
Puerto Rico	1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace: July 18, 2026 ET

Frequently asked questions

What does a Class I mean?

A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.

• Email
• X / Twitter
• Facebook